Oral submucous fibrosis is commonly seen in the adult population of the ethnic minorities in the UK, although its presentation in a child is rare. Whilst the condition is considered multifactorial and irreversible, we present a case of oral submucous fibrosis in a 12-year-old Bangladeshi boy whose cessation of habitual betel nut chewing and forcible mouth chewing exercises led to an improvement in his mouth opening, although his ability to protrude his tongue remained unaltered. The clinical features, pathogenesis and management of submucous fibrosis are described. The widespread use of betel quid among Asians in the UK is summarized and the importance of its recognition as a precancerous condition is emphasized.
immunoglobulin G (IgG) using the Automation ELISA IgG Kit manufactured by Automation INC. U S A . D a t a o b t a i n e d w e r e summarized using percentages and frequency tables. Results were analyzed using Epi-info version 3.0.Three hundred and fifty three pupils were recruited for the study. The overall prevalence rate for VZV infection was 66.3% with the value in males being 68.5% and in females 63.9%. The prevalence of VZV infection increased with age in both sexes. A high percentage of children (60%) were seropositive at 4-6 years.The study shows a 66.3% prevalence of VZV infection among children in Kaduna State. T h i s h i g h p r e v a l e n c e r a t e necessitates further studies to establish the burden of the problem in Nigeria and rationalize the institution of preventive measures against the infection, particularly i m m u n o c o m p r o m i s e d y o u n g children.
Results:
Conclusion:Received
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.